Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Hey guys a bit late but I wish you all a happy new year. Good luck to all and especially to swamp. Thank you for your informations and support. Greets from switzerland
Hey guys great news?!!!!!! We knew it's a real co. Greets from the beach in mallorca...
LOL kingAZZ was yelling 10.00 usd by the end of 2017. What a looser. 55 years old, sitting on his mothers laptop and still has to sleep in her bed because his crying every night... sivel snivel, he never ever had friends. What a bad life...
LOL...???
Totaly agree... Thanks swamp, my words...
Totaly agree
If I check 8-K i think 1:20...
The reduction in the number of authorized shares of Common Stock from 2,000,000,000 to 100,000,000 . What you think swamp?
Yes, I hope so too...
Forward and reverse splits are zero-sum games. If a company has 100 shares at $100, it's worth exactly as much as having 1,000 shares at $10 through a 10-for-1 split or 10 shares at $1,000 through a 1-for-10 reverse split.
It was clear that will happen. Better for up-listing, new eyes on the stock/new investors...
A reverse stock split is coming...
The Company’s Board of Directors will determine the timing to execute a reverse stock split, based on recent progress and
anticipated upcoming milestones, including the:
· Expected completion of a GLP toxicity study for the Company’s lead product, PRP, and subsequent preparation for FirstIn-Man
studies; and
· Execution of a strategy to address the Company’s capital structure, reduce debt and raise additional capital sufficient to
progress PRP through clinical development.
By undertaking these steps, the Company’s management team hopes to better position the Company for an up-listing of its
common stock to a national exchange to ensure the long-term future of the Company and create value for its stockholders.
Aha, hmmmmmm...!! these are your facts...... thanks for your response
Based on what momoney? Please facts... Are you invested? Short? Long?
Ok, penny matrix and I will buy your 100shares also for 0,014... but then you leave. Please. Ok??? Bäääh bäähh, snivel snivel
Good idea, thanks...
Hey shithead tought you sold all of your 100 shares and left... Have a good time... And now do it!!!!!
Thanks but you know that we are in 2017???
Very goood news. They are doing a great job. Step by step. 2017 will be a great year for PPCH.
Remember also:
PPCH has some big names behind it; Klaus Kutz, CMO of Propanc has prepared multiple investigational new drugs (IND) FDA applications for Sanofi, a $48 stock. Dr. Ralph Brandt of Propanc successfully led the tumor biology program for animal studies at Novartis. Novartis is now trading at $98 a share.
Perfect Team...
Thanks for the update swamp
Merry christmas to all too. Enjoy the time with family and friends... Cya guys
Yeah cool and I'm sure swamp will enjoy later too... PPCH and the gang for x-mas paaaartyyyy??
Lol... Sure it's x-mas soon. Everyone can come??
Hey cool idea. Thanks. I will go out now an have a couple beers. Swamp do you have time to go out for a beer or two? Minimum gain 5% and if we chanche to Wodka perhaps 40%. Quantum gereeeaat idea. Thanks again your the maaaaan.... Lol
Momo it's ok now... Like I explaned a couple times. News were on Sept 7. If application was before aug 30 the decision will be in dec. If not the decision will be in january. I did put the EMA link a couple times in my messages. I hope we will get news pretty soon. But I would prefer news in january to start with a booster into the new year...
Hi mentor. Thanks for the quick info... Hopefully they will answer pretty soon...
Pre buy 680k....
Thanks swamp...
Yes I hope so too. Again, If they Made the application afther Aug 30. The decision will be in january. Hope we will here something pretty soon... Mentor did you get an answer on your mail to the co?
Oh yes man I'm soooo happy for you too. You sold now all shares?? Yesss?? Ok thanks than you can leave now. And please stop vulgarity pm or write it public. Bye Bye we won't miss ya
Totally agree... Thats the way
Hi swamp. Yes, from today. Niiiice buy...
Thanks elkhunter. Yes, like I wrote in my summary. Within 90 days...
Just an other Information. The deadline for a decision in december was Aug 30. The news from ppch was on sep 7. So perhaps the decision will be in january. I don't know whe they started the application. Just for informition...
LOL...
Hi guys. Yes, last time I listened to the webinar a couple days later. And at the end James gave some answers to the questions in the chat. Also about dilution and interessting things like that. From there I have most of my informations... Everyone who is invested in this stock shoud listen to it. Have a nice day
Hi swamp and mentor. Nice to read you. I will also listen to the webinar later. I live in another country and dindn't have time. I also think next year will be great and interesting. Like I wrote in my summary and tried to inform the people. There will be some boosters for next year...
Here a summary:
Step 1
September 07, 2016
Application for Orphan Medicinal Product Designation in the EU for Pancreatic Cancer
November 01, 2016
Application for Orphan Medicinal Product Designation in the EU for Ovarian Cancer
Designation within 90 days.
EMA
This page lists the submission deadlines for applications for orphan designation.
In accordance with Article 5.5 of Regulation (EC) No 141/2000 , the Committee for Orphan Medicinal Products (COMP) will reach an opinion on a valid application for orphan designationwithin 90 days.
The dates below correspond to the COMP meetings falling on or just prior to day 90. Opinions may be reached earlier than day 90 if no questions are raised by COMP.
For further information on the procedure for designation, see how to apply for orphan designation.
Deadline for submission of applications / Start of procedure - day 1
(for validated applications ) / COMP meeting
20 July 2016 / 15 August 2016 / 3-4 November 2016
30 August 2016 / 12 September 2016 / 6-8 December 2016
28 September 2016 / 24 October 2016 / 17-19 January 2017
28 October 2016 / 21 November 2016 / 14-16 February 2017
25 November 2016 / 19 December 2016 / 14-16 March 2017
EMA application deadlines
Step 2
FDA applications
Step 3
Start Phase 1 in Q3 2017 (I thought James said in an interwiev that with this drugs phase 1 and 2 will be the same. Or something like that. But I am not sure with that).
Step 4
Cooperation with a big player
Perhaps Boehringer Ingelheim??
Scientific Advisor of PPCH Dr. Joseph M. Chalil, M.D., M.B.A., FACHE serves also as an Associate Director of Health Science Executives at Boehringer Ingelheim
Scientific advisors PPCH
Dr Joseph Chalil profile
Orphan drug BI
It will take time for these steps but. But I think it looks like we have some boosters for the next months.
This is my personal summary. This is no trading recommondation...
Hi swamp, looks like I am not banned anymore... Try to send the development timlines... Hope it works
PRP Entering Pre-Commercialization
Development Phase
• Successful scientific advice meeting with MHRA (UK), Apr, 2016.
• Orphan drug designation application filed for pancreatic cancer, Aug, 2016.
• Current activities:
1. Development of bioanalytical animal and human assays.
2. 28 day safety toxicokinetic study.
3. Development of manufacturing process & drug substance.
4. Initiate partnering discussions prior to and during Phase I
5. Phase I study in advanced cancer patients, solid tumors.